2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
12.05% |
4.23% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.87% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
12.37% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
14% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
13.79% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
12.38% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
12.73% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.41% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
9.35% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
9.35% |
0% |
2024-10-18 |
CUTR
Cutera, Inc.
|
Sell |
-5.26% |
12% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-6% |
-0.31% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-6.01% |
-0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-6.03% |
0.35% |
2024-10-07 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AXSM |
Buy
All
|
-7.81% |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.78% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
13.26% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
12.52% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
12.71% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
13.01% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
12.63% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
12.69% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
12.66% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.66% |
0% |
2024-10-16 |
CUTR
Cutera, Inc.
|
Sell |
-5.44% |
8% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-5.62% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-5.82% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-5.74% |
4.11% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-5.97% |
0.18% |
2024-10-07 |
The percentage of cash held in the portfolio is:
14.66%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.63% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.94% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
12.69% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
12.8% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
12.8% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
12.8% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
12.8% |
0% |
2024-10-15 |
CUTR
Cutera, Inc.
|
Sell |
-5.66% |
5.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-5.68% |
4.98% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-5.95% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-5.58% |
7.61% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-5.96% |
1.35% |
2024-10-07 |
The percentage of cash held in the portfolio is:
40.39%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.62% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.93% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
12.87% |
0% |
2024-10-14 |
CUTR
Cutera, Inc.
|
Sell |
-6.09% |
-1.33% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-5.79% |
3.74% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-5.99% |
0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-5.53% |
8.99% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-6.15% |
-1.12% |
2024-10-07 |
The percentage of cash held in the portfolio is:
92.12%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.44% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.67% |
-1.95% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-5.83% |
2.67% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-5.48% |
8.41% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-6.01% |
-0.42% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-5.54% |
8.5% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-5.81% |
4.05% |
2024-10-07 |
The percentage of cash held in the portfolio is:
104.57%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.69% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
12.92% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
12.92% |
0% |
2024-10-07 |
CUTR
Cutera, Inc.
|
Sell |
-5.99% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-6.01% |
-0.31% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-5.89% |
1.67% |
2024-10-03 |
IRTC
iRhythm Technologies, Inc.
|
Sell |
-6.06% |
0% |
2024-10-07 |
AXSM
Axsome Therapeutics, Inc.
|
Sell |
-6.06% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
92.47%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
11.6% |
0% |
2024-10-03 |
CUTR
Cutera, Inc.
|
Sell |
-6% |
0% |
2024-10-03 |
FATE
Fate Therapeutics, Inc.
|
Sell |
-6% |
0% |
2024-10-03 |
ORMP
Oramed Pharmaceuticals Inc.
|
Sell |
-6% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
106.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VREX |
Buy
All
|
0.6% |
CERS |
Buy
All
|
16.11% |
NVCR |
Sell
All
|
-11.63% |
Assets Rebalanced
None
2024-09-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
18.96% |
-8.98% |
2024-09-06 |
VREX
Varex Imaging Corporation
|
Sell |
-5.63% |
5.21% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.06% |
14.69% |
2024-09-05 |
The percentage of cash held in the portfolio is:
91.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
-1.56% |
Assets Rebalanced
None
2024-09-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
19.09% |
-8.42% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.04% |
-0.15% |
2024-09-09 |
VREX
Varex Imaging Corporation
|
Sell |
-5.99% |
-0.77% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.01% |
15.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
82.87%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-10.93% |
Assets Rebalanced
None
2024-09-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.92% |
-4.92% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.85% |
-2.44% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.33% |
5.56% |
2024-09-09 |
VREX
Varex Imaging Corporation
|
Sell |
-5.46% |
5.73% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-4.89% |
15.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
76.26%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AVXL |
Buy
All
|
6.46% |
PODD |
Sell
All
|
15.5% |
Assets Rebalanced
None
2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
24.76% |
15.22% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-2.73% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.3% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.37% |
6.04% |
2024-09-09 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.54% |
7.14% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.5% |
5.04% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.41% |
6.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
56.98%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
0.59% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
24.86% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.45% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.24% |
3.45% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-6.11% |
3.06% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.84% |
3.06% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.77% |
1.45% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.72% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
63.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AADI |
Sell
All
|
7.43% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.78% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.83% |
14.41% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.34% |
40.42% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.46% |
4.37% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
21.13% |
2.88% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.12% |
2.3% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-6.29% |
-0.03% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.44% |
9.69% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.91% |
-1.03% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.74% |
1.9% |
2024-09-05 |
The percentage of cash held in the portfolio is:
43.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
-5.48% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.88% |
1.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
25.09% |
12.73% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.04% |
31.25% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.13% |
-4.37% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.22% |
-3.99% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.95% |
-2.15% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.83% |
-5.48% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-5.97% |
7.41% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.47% |
11.39% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.89% |
1.88% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.8% |
3.32% |
2024-09-05 |
The percentage of cash held in the portfolio is:
51.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
8.41% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
10.83% |
3.11% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.4% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.9% |
11.4% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.86% |
27.5% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.12% |
-4.92% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.18% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.95% |
-2.56% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.51% |
-0.19% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.07% |
6.36% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.41% |
12.76% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.89% |
2.22% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.85% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
40.49%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-3.75% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.35% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
10.51% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.02% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.81% |
10.8% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.21% |
33.75% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.1% |
-5.46% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.84% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.23% |
0.26% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.46% |
0.85% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.05% |
6.89% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.29% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.86% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.87% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
30.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.45% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.43% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.78% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.11% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.78% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.16% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.96% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.32% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.17% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.46% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-5.97% |
7.17% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.39% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.23% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.73% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
21.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.85% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.89% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.54% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.37% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.55% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.18% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.87% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
20.59% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
19.84% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.21% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.44% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.25% |
3.86% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.45% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.97% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.79% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.3% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.75% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.78% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.55% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.06% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.5% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.54% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
21.04% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
21.03% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.5% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.21% |
3.61% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.83% |
5.44% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.13% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.91% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.97% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.88% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.15% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.27% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.64% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.36% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
21.19% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.69% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.31% |
2.72% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.93% |
4.42% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.03% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-6.03% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
23.19%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.25% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.16% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.53% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.88% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.75% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
22.65% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
20.08% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.4% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.4% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.99% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.49% |
0.15% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.77% |
7.14% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.64% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.56% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.33% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.55% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.76% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
15% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
21.24% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
21.24% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.97% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.07% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.18% |
-0.3% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.89% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-5.89% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.54% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.71% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.15% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.23% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.06% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.7% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.53% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
15% |
0% |
2024-08-28 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.88% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.03% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.03% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
32.01%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.5% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.58% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.27% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.35% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.29% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.77% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.77% |
0% |
2024-08-27 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.81% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
34.3%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.66% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.75% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.84% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.28% |
6.03% |
2024-08-23 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
56.43%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
3.38% |
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.84% |
4.43% |
2024-07-31 |
The percentage of cash held in the portfolio is:
105.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-1.57% |
Assets Rebalanced
None
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
13.02% |
-2.95% |
2024-07-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.34% |
12.45% |
2024-07-31 |
The percentage of cash held in the portfolio is:
92.32%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Buy
All
|
-2.48% |
Assets Rebalanced
None